BRADLEY FOSTER & SARGENT INC/CT Gilead Sciences, Inc. Transaction History

BRADLEY FOSTER & SARGENT INC/CT portfolio value:

$2.68M
portfolio value

BRADLEY FOSTER & SARGENT INC/CT quarter portfolio value change:

-0.19%
quarter

Gilead Sciences, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +0.30% 132 shares 3K $61.69 43.59K
Q2 2022 share Decrease -1.64% -726 shares 59K $61.81 43.46K
Q1 2022 share Decrease -9.40% -4.58K shares -915K $59.45 44.19K
Q4 2021 share Increase +10.37% 4.58K shares 455K $73.36 48.77K
Q3 2021 share Increase +0.08% 35 shares 46K $69.85 44.19K
Q2 2021 share Increase +2.80% 1.20K shares 265K $68.17 44.15K
Q1 2021 share Increase +0.26% 111 shares 280K $63.33 42.95K
Q4 2020 share Decrease -21.84% -11.96K shares -968K $56.43 42.84K
Q3 2020 share Increase +49.78% 18.21K shares 728K $60.52 54.81K
Q1 2020 share Decrease -2.00% -746 shares 310K $70.22 36.59K
Q4 2019 share Decrease -0.25% -93 shares 54K $60.43 37.34K
Q3 2019 share Decrease -0.26% -97 shares -164K $58.4 37.43K
Q2 2019 share Decrease -1.29% -490 shares 64K $61.67 37.53K
Q1 2019 share Decrease -3.99% -1.57K shares -5K $58.79 38.02K
Q4 2018 share Decrease -8.15% -3.51K shares -852K $56.02 39.59K
Q3 2018 share Increase +0.96% 410 shares 304K $68.57 43.11K
Q2 2018 share Decrease -25.40% -14.53K shares -1.29M $62.43 42.70K
Q1 2018 share Decrease -0.16% -90 shares 208K $65.91 57.23K
Q4 2017 share Decrease -10.91% -7.02K shares -1.10M $62.19 57.32K
Q3 2017 share Increase +8.71% 5.15K shares 1.02M $69.84 64.34K
Q2 2017 share Decrease -14.73% -10.22K shares -525K $60.63 59.19K
Q1 2017 share Decrease -33.31% -34.67K shares -2.73M $57.72 69.42K
Q4 2016 share Decrease -20.19% -26.32K shares -2.86M $60.39 104.09K
Q3 2016 share Decrease -5.91% -8.18K shares -1.24M $66.31 130.41K
Q2 2016 share Decrease -5.50% -8.06K shares -1.91M $69.49 138.60K
Q1 2016 share Decrease -1.54% -2.3K shares -1.60M $76.1 146.66K